MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Press releases

Displaying 11..18 of 18 - per page Previous page
Order by
New Fab inhibiting HCV intracellular replication available for licensing in
RidePharm announced today that it will license out the human monoclonal Fab inhibiting intracellular HCV replication More
CHI's Genome Tri-Conference 2002…The Molecular Medicine Marketplace
Genomics is revolutionizing the drug discovery & development process. Learn about cutting-edge breakthroughs and applications at this weeklong event that includes programs on Genomic Partnering, Human Genome Discovery, and Gene Functional Analys More
Target Validation in the Nervous System Using Herpes Simplex Viral Vectors
Target Validation for new drug discovery using large-scale functional genomics approaches More
Gene Bridges' 6-Month Trial License Available for Red/ET Recombination Technology
Gene Bridges announced that it is offering a cost-effective 6-month trial research licenses for the patented Red/ET Recombination technology More
CompuCyte Announces Restructuring, Development of High-Content Automated Cell Analysis System
CompuCyte Corporation announced today that it has concluded a restructuring of its operations, and the development of the next generation of laser scanning cytometer. More
11th International Conference on Cancer Gene Therapy
Oncolytic Herpes simplex virus treatment, OncoVEX with chemotherapy, Herpes simplex virus as a vaccine delivery platform More
CeNeS Pre-clinical Candidate rhGGF2 Cited as Potential Treatment for Schizophrenia
CeNeS Pharmaceuticals plc (LSE:CEN) today noted recent press coverage on the identification of a risk gene for schizophrenia that has implications for its pre-clinical candidate rhGGF2, which is a recombinant version of the protein coded by that gene More
Red/ET Recombination Course: Mastering Simple and Elegant DNA Engineering
atented technology that allows for cloning and precise modification of DNA molecules, regardless of size and composition. More
Displaying 11..18 of 18 - per page Previous page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Pharma Partnering Live
Press releases: Pharmalicensing current industry press releases.

© Copyright 1998-2010 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us